The impact of vedolizumab on COVID-19 outcomes among adult IBD patients in the SECURE-IBD registry

MLA

Xian Zhang, et al. “The Impact of Vedolizumab on COVID-19 Outcomes among Adult IBD Patients in the SECURE-IBD Registry.” Journal of Crohn’s & Colitis, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48f3896fcf66ee47d9d7b4a484075e49&authtype=sso&custid=ns315887.

APA

Xian Zhang, Jean-Frederic Colombel, Erica J. Brenner, Ryan C. Ungaro, Manasi Agrawal, & Michael D. Kappelman. (2021). The impact of vedolizumab on COVID-19 outcomes among adult IBD patients in the SECURE-IBD registry. Journal of Crohn’s & Colitis.

Chicago

Xian Zhang, Jean-Frederic Colombel, Erica J. Brenner, Ryan C. Ungaro, Manasi Agrawal, and Michael D. Kappelman. 2021. “The Impact of Vedolizumab on COVID-19 Outcomes among Adult IBD Patients in the SECURE-IBD Registry.” Journal of Crohn’s & Colitis, April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48f3896fcf66ee47d9d7b4a484075e49&authtype=sso&custid=ns315887.